Our trial of ondansetron as a treatment for hallucinations in Parkinson's is restarting Date 22 November 2024
8 remarkable things we achieved together in 2019, and recent years Date 17 December 2019 2019 was another exciting year of progress. Here are 8 of the highlights, and 8 ways you can still get involved.
Progress in gene therapy treatment for Parkinson's Date 5 December 2019 Researchers, funded by Parkinson's UK, have produced positive results in mice for a gene therapy treatment that directly targets the production of the alpha-synuclein protein.
Could sleep boost waste disposal in the brain and prevent Parkinson’s? Date 1 November 2019 Alongside Alzheimer’s Research UK, we’re funding new research that will investigate whether boosting the brain’s self-cleaning system could be the key to new treatments.
Revolutionary research advocate Ken Bowler dies aged 76 Date 23 October 2019 The Parkinson’s community in Scotland, and beyond, has lost one of its giants with the passing of Professor Ken Bowler. Ken revolutionised the relationship between researchers and people living with Parkinson’s.
Ex-footballers more likely to get Parkinson's, research finds Date 22 October 2019 Former professional footballers are more likely to die with a neurodegenerative condition such as dementia or Parkinson's than the general population, according to new research.
Can cannabis stop Parkinson's hallucinations? Date 14 October 2019 A pioneering clinical trial will investigate if cannabidiol (CBD) – a compound found in the cannabis plant – can treat hallucinations and delusions in people living with Parkinson’s.
Promising results from a phase II study for people with early-stage Parkinson’s Date 8 October 2019 A phase II clinical trial of tavapadon, a drug developed by Cerevel Therapeutics, has shown improvements in movement symptoms. The results have been announced on the company website.
Research shows at home exercise improves movement symptoms Date 19 September 2019 Researchers have shown that those taking part in a home-based exercise programme experienced improvements in their motor symptoms.
Prostate drug shows promise in Parkinson’s Date 17 September 2019 A drug used to treat enlarged prostates may have exciting potential for slowing down Parkinson's, according to research published in the Journal of Clinical Investigation.
Hormone treatment slows Parkinson's symptoms in mice Date 20 August 2019 Researchers have shown that boosting levels of oestrogen in the brains of mice improved symptoms by slowing the build-up of the toxic protein alpha-synuclein.
